Gallium 68 Triveoctin

N/A

Report date: 2025/11/21 17:41:02
NME

Base Information

Drug NameGallium 68 Triveoctin
Drug Alias NameIntegrin αvβ8 – 68Ga-Triveoctin
ClassificationRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) > Radionuclide Imaging agentSmall molecules +[5] 
Mechanisms of ActionPositron-emission tomography enhancersintegrin alpha V/beta 8 modulators
Targetsintegrin alpha V/beta 8
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTrimt GmbH
China Registration ClassN/A

Develop Information

Active CompaniesTrimt GmbH
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A